Scientific Sessions 2025  /  Cardiometabolic and Lifestyle Interventions for AF    /  Discussant: DECAF
Logo

American Heart Association

  37
  0

Final ID:

Discussant: DECAF

  • Russo, Andrea  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Andrea Russo: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott, Bayer, Boston Scientific, Medtronic and Novartis:Active (exists now) ; Royalties/Patent Beneficiary:Royalties (writing/editing): UpToDate:Active (exists now) ; Other (please indicate in the box next to the company name):Fellowship support: Medtronic:Active (exists now) ; Consultant:Abbott, Atricure, Bayer, Sanofi:Past (completed) ; Consultant:Biosense Webster, Biotronik, Boston Scientific, Medtronic, Orchestra BioMed, PaceMate :Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiometabolic and Lifestyle Interventions for AF  

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Discussant: DARE-AF

Yancy Clyde

Dapagliflozin to Reduce Atrial Fibrillation Burden After Catheter Ablation for Atrial Fibrillation in Patients Without Diabetes or Heart Failure: The DARE-AF Randomized Clinical Trial

Zhao Zixu, Dong Jz, Ma Changsheng, Yang Zejun, Jiang Chao, Wang Yiping, Xu Hui, Xu Yang, Sang Caihua, Long Deyong, Du Xin

More abstracts from these authors:
Panelist

Russo Andrea

Just Five More Minutes! Devices, AF and AHRE's - New data, new Guidelines

Indik Julia, Russo Andrea

You have to be authorized to contact abstract author. Please, Login
Not Available